45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
12,685
Insurances with rates
18
CPT / HCPCS codes
10,082
Most expensive procedures (gross)
Q2041
$2,668,960
TISAGENLECLEUCEL 250000000 CELLS IV SUSP
Gross
$19,064,000
Q2054
$535,601
LISOCABTAGENE MARALEUCEL 70000000 CD8+ CELLS/ML IV SUSP
Gross
$3,825,723
Q2055
$532,539
IDECABTAGENE VICLEUCEL 460000000 CELLS IV SUSP
Gross
$3,803,850
Q2041
$335,720
AXICABTAGENE CILOLEUCEL 200000000 CELLS IV SUSP
Gross
$2,398,000
Q2053
$335,720
BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP
Gross
$2,398,000
J2326
$147,469
NUSINERSEN 12 MG/5ML IT SOLN
Gross
$1,053,353
A9513
$67,581
LUTETIUM LU 177 DOTATATE 370 MBQ/ML IV SOLN
Gross
$482,719
Q2043
$63,103
SIPULEUCEL-T 50000000 CELLS IV SUSP
Gross
$450,738
J9043
$59,350
CABAZITAXEL 60 MG/6ML IV SOLN
Gross
$423,932
J9226
$50,583
HISTRELIN ACETATE (CPP) 50 MG SC KIT
Gross
$361,308
J0223
$44,245
GIVOSIRAN SODIUM 189 MG/ML SC SOLN
Gross
$316,037
J1823
$44,016
INEBILIZUMAB-CDON 100 MG/10ML IV SOLN
Gross
$314,400
C9293
$43,579
GLUCARPIDASE 1000 UNITS IV SOLR
Gross
$311,278
J9359
$39,016
LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR
Gross
$278,686
J9228
$37,239
IPILIMUMAB 200 MG/40ML IV SOLN
Gross
$265,992
J0567
$36,161
CERLIPONASE ALFA 2 X 150 MG/5ML VE KIT
Gross
$258,293
J9269
$34,027
TAGRAXOFUSP-ERZS 1000 MCG/ML IV SOLN
Gross
$243,048
J9229
$32,786
INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR
Gross
$234,185
J2507
$30,989
PEGLOTICASE 8 MG/ML IV SOLN
Gross
$221,350
J3357
$30,854
USTEKINUMAB 90 MG/ML SC SOL PRESYRG
Gross
$220,385
J2327
$30,083
RISANKIZUMAB-RZAA 150 MG/ML SC SOL PRESYRG
Gross
$214,882
J0202
$29,982
ALEMTUZUMAB 12 MG/1.2ML IV SOLN
Gross
$214,159
J9266
$27,705
PEGASPARGASE 750 UNIT/ML IJ SOLN
Gross
$197,896
J9281
$25,649
MITOMYCIN 80 (2 X 40) MG UL SOLR
Gross
$183,204
J1303
$24,746
RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN
Gross
$176,758
J9600
$23,510
PORFIMER SODIUM 75 MG IV SOLR
Gross
$167,926
J2350
$21,888
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$156,343
J0638
$21,555
CANAKINUMAB 150 MG/ML SC SOLN
Gross
$153,967
J1246
$21,100
DINUTUXIMAB 17.5 MG/5ML IV SOLN
Gross
$150,717
J9309
$19,886
POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR
Gross
$142,042
J3241
$18,163
TEPROTUMUMAB-TRBW 500 MG IV SOLR
Gross
$129,736
J3245
$18,105
TILDRAKIZUMAB-ASMN 100 MG/ML SC SOL PRESYRG
Gross
$129,322
J7205
$16,884
ANTIHEM FACT (BDD-RFVIIIFC) 6000 UNITS IV SOLR
Gross
$120,600
J9272
$16,492
DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN
Gross
$117,800
J3357
$15,427
USTEKINUMAB 45 MG/0.5ML SC SOL PRESYRG
Gross
$110,193
J7189
$14,868
COAGULATION FACTOR VIIA RECOMB 5 MG IV SOLR
Gross
$106,200
J9316
$14,659
PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN
Gross
$104,708
90288
$14,364
BOTULISM IMMUNE GLOBULIN HUMAN 100 MG IV SOLR
Gross
$102,600
J9307
$13,684
PRALATREXATE 40 MG/2ML IV SOLN
Gross
$97,740
J2562
$13,397
PLERIXAFOR 24 MG/1.2ML SC SOLN
Gross
$95,693
J7170
$13,372
EMICIZUMAB-KXWH 105 MG/0.7ML SC SOLN
Gross
$95,517
J7686
$12,835
TREPROSTINIL 200 MG/20ML IJ SOLN
Gross
$91,679
J0896
$12,687
LUSPATERCEPT-AAMT 75 MG SC SOLR
Gross
$90,620
J9022
$12,033
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$85,947
J9037
$11,863
BELANTAMAB MAFODOTIN-BLMF 100 MG IV SOLR
Gross
$84,734
C1882
$11,575
HB ICD INOGEN X4 DF4 G148
Gross
$82,676
J1640
$11,519
HEMIN 350 MG IV SOLR
Gross
$82,276
J9119
$11,425
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$81,609
J9153
$11,068
DAUNORUBICIN-CYTARABINE LIPO 44-100 MG IV SUSR
Gross
$79,056
J9144
$10,656
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$76,117
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2041 | TISAGENLECLEUCEL 250000000 CELLS IV SUSP | $19,064,000 | $2,668,960 | — | — | 4 |
| Q2054 | LISOCABTAGENE MARALEUCEL 70000000 CD8+ CELLS/ML IV SUSP | $3,825,723 | $535,601 | — | — | 2 |
| Q2055 | IDECABTAGENE VICLEUCEL 460000000 CELLS IV SUSP | $3,803,850 | $532,539 | — | — | 19 |
| Q2041 | AXICABTAGENE CILOLEUCEL 200000000 CELLS IV SUSP | $2,398,000 | $335,720 | — | — | 6 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 200000000 CELLS IV SUSP | $2,398,000 | $335,720 | — | — | 5 |
| J2326 | NUSINERSEN 12 MG/5ML IT SOLN | $1,053,353 | $147,469 | — | — | 4 |
| A9513 | LUTETIUM LU 177 DOTATATE 370 MBQ/ML IV SOLN | $482,719 | $67,581 | — | — | 2 |
| Q2043 | SIPULEUCEL-T 50000000 CELLS IV SUSP | $450,738 | $63,103 | — | — | 9 |
| J9043 | CABAZITAXEL 60 MG/6ML IV SOLN | $423,932 | $59,350 | — | — | 7 |
| J9226 | HISTRELIN ACETATE (CPP) 50 MG SC KIT | $361,308 | $50,583 | — | — | 5 |
| J0223 | GIVOSIRAN SODIUM 189 MG/ML SC SOLN | $316,037 | $44,245 | — | — | 2 |
| J1823 | INEBILIZUMAB-CDON 100 MG/10ML IV SOLN | $314,400 | $44,016 | — | — | 9 |
| C9293 | GLUCARPIDASE 1000 UNITS IV SOLR | $311,278 | $43,579 | — | — | 1 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $278,686 | $39,016 | — | — | 3 |
| J9228 | IPILIMUMAB 200 MG/40ML IV SOLN | $265,992 | $37,239 | — | — | 5 |
| J0567 | CERLIPONASE ALFA 2 X 150 MG/5ML VE KIT | $258,293 | $36,161 | — | — | 5 |
| J9269 | TAGRAXOFUSP-ERZS 1000 MCG/ML IV SOLN | $243,048 | $34,027 | — | — | 7 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $234,185 | $32,786 | — | — | 4 |
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $221,350 | $30,989 | — | — | 7 |
| J3357 | USTEKINUMAB 90 MG/ML SC SOL PRESYRG | $220,385 | $30,854 | — | — | 7 |
| J2327 | RISANKIZUMAB-RZAA 150 MG/ML SC SOL PRESYRG | $214,882 | $30,083 | — | — | 6 |
| J0202 | ALEMTUZUMAB 12 MG/1.2ML IV SOLN | $214,159 | $29,982 | — | — | 3 |
| J9266 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $197,896 | $27,705 | — | — | 2 |
| J9281 | MITOMYCIN 80 (2 X 40) MG UL SOLR | $183,204 | $25,649 | — | — | 7 |
| J1303 | RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN | $176,758 | $24,746 | — | — | 9 |
| J9600 | PORFIMER SODIUM 75 MG IV SOLR | $167,926 | $23,510 | — | — | 3 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $156,343 | $21,888 | — | — | 6 |
| J0638 | CANAKINUMAB 150 MG/ML SC SOLN | $153,967 | $21,555 | — | — | 3 |
| J1246 | DINUTUXIMAB 17.5 MG/5ML IV SOLN | $150,717 | $21,100 | — | — | 2 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $142,042 | $19,886 | — | — | 4 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $129,736 | $18,163 | — | — | 6 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SC SOL PRESYRG | $129,322 | $18,105 | — | — | 6 |
| J7205 | ANTIHEM FACT (BDD-RFVIIIFC) 6000 UNITS IV SOLR | $120,600 | $16,884 | — | — | 6 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $117,800 | $16,492 | — | — | 6 |
| J3357 | USTEKINUMAB 45 MG/0.5ML SC SOL PRESYRG | $110,193 | $15,427 | — | — | 4 |
| J7189 | COAGULATION FACTOR VIIA RECOMB 5 MG IV SOLR | $106,200 | $14,868 | — | — | 4 |
| J9316 | PERTUZ-TRASTUZ-HYALURON-ZZXF 80-40-2000 MG-MG-U/ML SC SOLN | $104,708 | $14,659 | — | — | 5 |
| 90288 | BOTULISM IMMUNE GLOBULIN HUMAN 100 MG IV SOLR | $102,600 | $14,364 | — | — | 5 |
| J9307 | PRALATREXATE 40 MG/2ML IV SOLN | $97,740 | $13,684 | — | — | 9 |
| J2562 | PLERIXAFOR 24 MG/1.2ML SC SOLN | $95,693 | $13,397 | — | — | 7 |
| J7170 | EMICIZUMAB-KXWH 105 MG/0.7ML SC SOLN | $95,517 | $13,372 | — | — | 2 |
| J7686 | TREPROSTINIL 200 MG/20ML IJ SOLN | $91,679 | $12,835 | — | — | 7 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SC SOLR | $90,620 | $12,687 | — | — | 6 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $85,947 | $12,033 | — | — | 5 |
| J9037 | BELANTAMAB MAFODOTIN-BLMF 100 MG IV SOLR | $84,734 | $11,863 | — | — | 6 |
| C1882 | HB ICD INOGEN X4 DF4 G148 | $82,676 | $11,575 | — | — | 3 |
| J1640 | HEMIN 350 MG IV SOLR | $82,276 | $11,519 | — | — | 12 |
| J9119 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $81,609 | $11,425 | — | — | 4 |
| J9153 | DAUNORUBICIN-CYTARABINE LIPO 44-100 MG IV SUSR | $79,056 | $11,068 | — | — | 11 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $76,117 | $10,656 | — | — | 3 |
Showing top 50 of 12,685 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.